Events

Invitrocue (Singapore) and IVIM Technology (Korea) are honored to co-host this webinar on preclinical evaluation strategies for immuno oncology therapeutics. We warmly invite APAC researchers to join us and learn how intravital imaging and humanized mouse technologies can help visualize immune responses and support the development of next-generation immunotherapies.

Date & Time: Thursday, February 26, 2026 | 2:00 PM (SGT) 3:00PM (KST)

Duration: 20min (Invitrocue) + 20min (IVIM Technology) + 10min (Q&A)

Overview

• Invitrocue will present “Beyond T-Cells: Targeting Pathological Macrophages with the C10 Universal Cancer Vaccine to Optimize Checkpoint Immunotherapy,” highlighting an emerging approach to remodel the tumor microenvironment by targeting pathological macrophages to enhance checkpoint inhibitor responses.
• 
  
• IVIM Technology will demonstrate how intravital microscopy enables real-time, high-resolution visualization of tumor-infiltrating lymphocytes (TILs) and bispecific antibody activity within living tumors, revealing dynamic immune activation and treatment responses to advance immuno-oncology research.

 What You Will Learn

• 1. Key immuno-oncology therapies: Immune checkpoint inhibitors, TILs, bispecific antibodies

• 2. How in vivo mouse models reveal immune and drug responses in real time

• 3. Practical examples by cancer type/organ to connect preclinical results to clinical relevance